Windtree Therapeutics Inc
WINT
Market Cap$3.64M
Close$
$-0.00
100.1% downside
Current Fair Value
100.1% downsideOvervalued by 100.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.64 Million |
|---|---|
| Enterprise Value | $3.35 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.1 |
| Beta | 0.91 |
| Outstanding Shares | 52,583,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -9.54 |
|---|---|
| PEG | 62.54 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.16 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.45 |
| Debt to Equity | 0.47 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Windtree Therapeutics Inc
31 employeesWindtree Therapeutics, Inc. is advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders to treat patients in moments of crisis. Using new clinical approaches, Windtree is developing a multi-asset franc...